Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    10075741 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: Dasatinib

Indicates status has not been verified in more than two years